Same Indication

Nivolumab vs Valsartan

Nivolumab vs Valsartan: Overview

This comparison examines the pharmacological differences between Nivolumab and Valsartan.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Valsartan: Angiotensin II type 1 receptor blocker.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Valsartan — 6 hours.

Chemical Properties

Molecular Formula: Valsartan — C24H29N5O3.

Molecular Weight: Valsartan — 435.5190 g/mol.

Type: Nivolumab — Antibody; Valsartan — Small molecule.